Rossari Biotech IPO – Growth and Good Chemistry

  • Date 11th July; IPO Opens 13-15th July at ₹423-425/share
  • Small Cap: 2,200 Mkt cap
  • Sector – Specialty Chemicals
  • Valuations: P/E 30.7 times TTM, P/B 6.9 times (Post IPO)
  • Advice: SUBSCRIBE

jainmatrix investments, rossari

Summary

  • Overview: Rossari Biotech is a leading Indian textile and specialty chemical firm. Revenues, EBITDA and profit for FY20 were ₹ 603.8 cr., ₹ 105 cr. and ₹ 65 cr. resp., and grew at 32.3%, 67.6% and 66 % resp. over the last 3 years. Rossari has seen a rapid growth in recent times, and has a balanced product portfolio and a large number of domestic customers. Growth plans look promising with the planned Dahej plant. The debt is low, and balance sheet looks healthy with good return ratios. Expansion plans have been funded mostly from internal cash generation. The firm is small but looks nimble in terms of product formulations, R&D, new export markets, etc. At a P/E of 30.7 times FY20 earnings, the valuation is expensive. However the current growth rates justify this valuation.
  • Risks: 1) Valuations look expensive 2) delay in new Dahej plant could affect growth 3) Covid19 infection can affect Revenues. It can also affect manufacturing operations.
  • Opinion: Investors can SUBSCRIBE to this IPO with a 2 year perspective.

Here is a note on Indian Rossari Biotech (Rossari) IPO.

IPO highlights

  • The IPO opens: 13-15th July 2020 with the Price band ₹423-425 per share.
  • There is a Fresh issue of ₹ 50 crore, and an Offer for Sale of 10,500,000 shares by promoters. The FV is ₹ 2. The IPO in total will collect ₹ 500 cr.
  • The IPO share quotas for QIB, NII and retail are in ratio of 50:15:35.
  • The unofficial, grey market premium is ₹125-130 /share, indicating a 30% upside. This is a positive.

Introduction

  • Rossari Biotech is a leading Indian textile and specialty chemical firm with over a decade history of innovative, agile, and rapid growth. They provide customized solutions to industrial and production requirements of customers through a diversified chemical products portfolio. Building upon expertise in textiles sector, they have successfully diversified into the home, personal care, animal health and nutrition and performance chemicals markets.
  • Revenues, EBITDA and profit for FY20 were ₹ 603.8 cr., ₹ 105 cr. and ₹ 65 cr. resp.
  • It has 3,783 employees. The Silvassa (in Union Territory of Dadra & Nagar Haveli) mfg. facility has a capacity of 120,000 MTPA. They have a dedicated team of 22 employees in R&D facilities situated at Silvassa mfg. facility and another one in Mumbai.
  • Rossari relevant market includes following Segments – Home Care, Personal Care, Textile Chemicals, Construction Chemicals, Paints & Coatings, and Water Treatment Chemicals.
  • Promoters of the company are Edward Menezes, 59, and Sunil Chari, 54. They started together in 2003, and are career technocrats having 45 years of experience cumulatively in specialty chemicals industry.
  • The two Promoters hold about 82% pre IPO and 62% shares post IPO and are the primary sellers.
  • On 10th July, Rossari Biotech raises Rs 149 cr. from anchor investors, with top 3 MFs key investors.

Financials of Rossari

jainmatrix investments, rossari biotech IPOFig 1 – Financials

  • The 4 years financials shows rapid revenue growth, and improving EBITDA and profit margins.
  • Over 3 years, Revenues, EBITDA and Profits grew at 32.3%, 67.6% and 66 % resp. See Fig 1.
  • The firm has grown Operating Profits sharply, but the working capital has grown in FY20, reducing the final Cash from Operations, see Fig 2.

jainmatrix investments, rossari biotech IPOFig 2 – Free Cash Flows

  • The firm is also making significant investments into a new manufacturing facility at Dahej, so the Free Cash Flow has turned negative in FY20.
  • The firm has in recent years grown its offering in the Home, personal care and performance chemicals (HPPC) segment and this is 47% of its revenues, see Fig 3.
  • Per news reports, Rossari seized the opportunity after Covid19 to make Hand Sanitizers and Disinfectant liquids, which saw a massive demand spurt in recent months.

jainmatrix investments, rossari biotech IPOFig 3 – Key Product Segments

  • The firm has also grown its exports pie and now exports to 18 countries including Vietnam, Bangladesh and Mauritius. It plans to grow the international business in future. See Fig 4.

jainmatrix investments, rossari biotech IPOFig 4 – Exports

  • The firm has grown its manufacturing capacity steadily at the Silvassa plant, see Fig 5.
  • The Capacity utilization has been over 80% for the last 2 years.
  • Rossari is setting up a new plant at Dahej of 1,32,000 MTPA. This is expected to go on stream in FY21. There is no expansion planned at Silvassa, perhaps the plant area is saturated.
  • Funding for this plant has been from internal cash generation as well as loans.
  • The rapid revenue growth has come at the cost of slightly lower average realizations from products.

jainmatrix investments, rossari biotech IPOFig 5 – Manufacturing

Chemicals Industry Outlook in India

  • We recently published a report, see Indian Specialty Chemicals Sector – A Spotlight. Do read this.
  • In brief, we are quite positive on Chemicals and particularly Specialty Chemicals sector. Particularly the opportunities are around replacement of Chinese supply for both domestic and global demand.

Benchmarking

We compare Rossari to Chemical industry peers in India. See Fig 6.

jainmatrix investments, rossari biotech IPOFig 6 – Benchmarking

  • It’s the smallest firm by revenues in this group. In terms of valuations, ie P/E and P/B, it is on the higher side. The margins are also on the lower side, both Operating and Profit.
  • Growth numbers are leading, both Sales and Profits, indicating a good burst of recent success.
  • In terms of ROE it’s a leader, and on RoCE above average. Post IPO there is some 5% dilution to equity, so the number may be reduced to that extent.
  • The D/E looks healthy, even though the company is in expansion mode. This is good.
  • In a growth phase, one does not expect dividends from small cap firms, so its not an issue.
  • Plans are afoot around growing exports, and this should help Rossari improve revenues and realization.

Risks and Negatives for Rossari and the IPO

  • Valuations at PE 30.7 times of FY20 earnings looks expensive.
  • Any delay in the Dahej plant in terms of commissioning and a start of production in FY21 will slow the revenue momentum at Rossari as the current plant is close to capacity utilization.
  • The IPO is primarily an offer to sell by promoters, so the firm gains only by Rs 50 crores of capital raised by fresh issue of shares. Conversely the equity capital will not be much diluted.
  • In FY20 domestic sales were 86% of revenues, a low ratio. There is opportunity is in growing exports.
  • When we see a sharp burst of growth in financials in 2-3 years before an IPO, we worry that such growth may not be sustained in the next 5-10 years after a successful listing.
  • The primarily promoter owned firm has not benefited from the oversight, partnership and approval of Private Equity or other investors, so future success of Rossari is highly dependent on Promoters.
  • This is the first IPO after a pause of several months. It’s possible that hurt investors may not flock to this IPO like in Jan-Feb this year. But this may actually be to the benefit of investors in this IPO.
  • Covid19 epidemic is still gathering momentum in India, and till we see a fall in infection numbers, both investors and overall demand in the economy may be subdued. However the firm has grabbed the opportunity by making Covid safety products such as d Sanitizers and Disinfectant liquids.
  • This is a B2B space, so verification and confirmation of customers, brands and quality is difficult.

Overall Opinion and Recommendation

  • Specialty Chemicals sector is a high potential growth sector.
  • Rossari Biotech has seen a rapid growth in recent times, and has a balanced product portfolio and a large number of domestic customers. Growth plans look promising with the planned Dahej plant.
  • The debt is low, and balance sheet looks healthy with good return ratios. Expansion plans have been funded mostly from internal cash generation.
  • The firm is small but looks nimble in terms of product formulations, R&D, new export markets, etc.
  • At a P/E of 30.7 times FY20 earnings, the valuation is expensive. However the current growth rates justify this valuation.
  • Risks: 1) Valuations look expensive 2) delay in new Dahej plant could affect growth 3) Covid19 infection can affect Revenues. It can also affect manufacturing operations.
  • Opinion: Investors can SUBSCRIBE to this IPO with a 2 year perspective.

Disclaimer

This document has been prepared by JainMatrix Investments Bangalore (JM), and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of JM. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, JM has not independently verified the accuracy or completeness of the same. Punit Jain discloses that he has no stake ownership or known financial interests in Rossari Biotech or any group company. Punit Jain intends to apply for this IPO. Neither JM nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient’s particular circumstances and, in case of doubt, advice should be sought from an Investment Advisor. Punit Jain is a registered Research Analyst under SEBI (Research Analysts) Regulations, 2014. JM has been publishing equity research reports since Nov 2012. Any questions should be directed to the director of JainMatrix Investments at punit.jain@jainmatrix.com.

Colgate Palmolive (India) – A Shiny Idea

  • Date: 25th May 2020 ;  CMP: Rs 1,313 
  • Large Cap – Mkt Cap Rs. 35,700 and Industry: Consumer – FMCG 
  • Valuation: P/E at 37.3 
  • Advise: BUY 

jainmatrix investments, colgate palmolive

Summary

Overview: Colgate Palmolive (India) is the leader in India’s oral care market with a 49% share. Their range includes toothpastes, toothpowder, toothbrushes, mouthwashes and personal care products products under the Colgate and Palmolive brands. FY20 revenues were ₹ 4,574 crores, and profits ₹ 816 cr. CPL today has one of the widest distribution networks in India – a logistical marvel with 61 lakh retail outlets. Most of the products of CPL were part of the ‘Essential products’ that were allowed to be distributed even during lockdown. Also by May 4th, all CPL plants were allowed to open. Given all this, we feel that CPL will be less disrupted than most consumer firms through Q1 and Q2 FY21 due to the lockdown.

Key Risks: 1) Covid 19 lockdown in Q1FY20 will impact both mfg. and the demand as supply chains as well as outlets have been closed 2) strong competition 3) Indian preferences for natural and ayurvedic products

Advice: BUY with a May 2022 target of ₹ 1,555, a 18.5% gain

The entire report in PDF form is available hereJainMatrix Investments_Colgate Palmolive Ltd_May2020

Disclaimer and Disclosures 

  • Punit Jain has no holding in CPL. In addition, JM and its promoters/ employees have no financial interest in CPL and no known material conflict of interest as on date of publication of this report.
  • This document has been prepared by JainMatrix Investments Bangalore (JM), and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of JM. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, JM has not independently verified the accuracy or completeness of the same. Neither JM nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient’s particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor.
  • JM has been publishing equity research reports since Nov 2012, and is registered with SEBI as a Research Analyst since 2016. Any questions should be directed to the director of JainMatrix Investments at jain@jainmatrix.com

Indian Speciality Chemicals Sector – A Spotlight

The Indian economy has been hit by the Covid-19 epidemic. Even in this tough market, we find that the Indian Specialty Chemicals sector has the potential to not just survive, but actually grow rapidly.

Introduction

  • The Chemical sector constitutes a significant part of Indian economy. It’s a very diversified industrial sector, as chemicals cover over 70,000 commercial products. India is the 6th largest producer of chemicals globally and 3rd largest in Asia. Export were US$ 19.1 billion during the year 2018-19.
  • The Govt. of India allows 100% FDI in the chemical sector. The mfg. of most of the chemical products like organic/ inorganic, pesticides and dyestuffs is delicensed except hazardous products. It contributes 16% of the mfg. sector GDP.
  • Industry has 5 segments: basic chemicals, agrochem, specialty chem, pharma and consumer products. The specialty chemicals constitute 22% of total chemicals market in India.
  • Chemicals are the basic building blocks of a range of end-user products like drugs & pharmaceuticals, agrochemicals, paints, construction material, auto parts, textiles, and packaging, among others.
  • Specialty chemicals are value added chemicals, they are used towards specific end use applications They are performance or quality products, niche and high value. These provide a wide variety of functionality on which many other industry sectors rely.

Chemical Sector Notes

  • India is an attractive hub for chemical companies. The Indian chemical industry is a global outperformer in terms of Total Returns to Shareholders (TRS), source McKinsey & Co report. This has resulted in rapid growth for chemical industry of India. See Fig 1. It can be seen that The Indian Chemical industry enjoys superior returns.

jainmatrix investments, chemicalsFig 1. CAGR of TRS, source McKinsey & Co

  • China has implemented strict environmental norms, because of which many Chinese capacities are shutting down, which is benefitting large organised Indian players.The Ministry of Environment of China stated that 70% of companies inspected failed to meet the air pollution standards. Large global chemical supply chains may look at India as an alternative mfg. location.
  • The Coronavirus lockdown in China in Jan-Mar 2020 revealed and exposed global dependency on Chinese mfg. China is now seen to be an unreliable partner and many countries are actively looking at alternate manufacturing locations to de risk supply chain. Loss of China (37 % share) as a reliable partner and continued shifts from EU/Japan (16 %/4 % share) means share of India (3%) will rise. India will gain advantage because of availability of talent for mfg. and R&D.
  • Fig 2 represents share of countries in sales of global chemical industry.

jainmatrix investments, specialty chemicalsFig 2. Region wise sales of Chemicals

  • Today, India has a chemical trade deficit of $15 billion. There is a massive opportunity for import substitution – for Indian demand, as well as exports, of such products.
  • INR to Dollar is now Rs 75.5, it is weakening so imports are becoming expensive. So, import substitution for chemical products is attractive.
  • In India, during lockdown due to COVID, there was a disruption in supply chains and speciality chemicals also faced logistics (supply chain) and labour problems. But chemical industry is expected to be less impacted by COVID because most companies have fully or partially restarted their operations as it supplies chemicals to essential sectors like pharma, hygiene, personal health and agrochemicals.

Key Players

  • Fig 3 shows contribution of domestic and exports revenues to the total revenues of firms.

jainmatrix investments, speciality chemicalsFig 3. Revenue from exports

  • We have done a benchmarking exercise to compare the Chemical industry’s sector players. Fig. 4 depicts the comparison between different Indian companies on basis of vital parameters.

jainmatrix investments, specialty chemicalsFig. 4 Benchmarking

  • We can see that Vinati Organics has the highest contribution of export to revenues and Aarti the lowest.
  • In terms of size and scale SRF and Aarti lead.

jainmatrix investments, specialty chemicalsFig 5 – Relative Share Prices 

  • Over a 2 year period we can see the relative share prices.
  • Vinati and Navin have gained the most while Aarti and SRF the least among these firms.

Conclusion

  • Indian chemicals players will benefit from the expanding specialty chemicals market globally led by growing new applications alongside manufacturing shifts from China ― which has been battered by reliability and transparency woes; and EU, due to its ageing workforce; focus on innovation, and M&As.
  • There exists a good opportunity for Indian chemicals players to scale up and tap the opportunities for import substitution and exports.

Disclaimer

This document has been prepared by JainMatrix Investments Bangalore (JM), and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of JM. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, JM has not independently verified the accuracy or completeness of the same. Punit Jain has no known financial interests in any firm mentioned here. Neither JM nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient’s particular circumstances and, in case of doubt, advice should be sought from an Investment Advisor. Punit Jain is a registered Research Analyst under SEBI (Research Analysts) Regulations, 2014. JM has been publishing equity research reports since Nov 2012. Any questions should be directed to the director of JM at punit.jain@jainmatrix.com.

SBI Cards – IPO is an Easy Transaction

  • IPO Opens 2-5th Mar at 750-755/share 
  • Large Cap: 71,000 cr. Mkt cap
  • Sector – BFSI, Credit Cards
  • Valuations: P/E 51.4 times TTM, P/B 14.6 times (Post IPO)
  • Advice: SUBSCRIBE

Summary

  • Overview: SBIC offers credit cards to individual cardholders and corporate clients for a range of lifestyle, rewards, travel and fuel and shopping needs. SBIC is the 2nd largest CC issuer in India, with a 18% market share. Revenues, EBITDA and profit for FY19 were ₹6,999 cr., ₹2,430 cr. and ₹863 cr. resp. PAT for H1 FY20 is ₹725 cr. Revenues, EBITDA & PAT have grown at a CAGR of 44.6%, 48.3% and 52.1% resp. from FY17-FY19. SBIC’s financials are robust. SBIC has generated high RoE, NIM; while also maintaining sufficient capital buffer through high CAR & low D/E. SBIC is a well-managed firm financially. Credit cards are an underpenetrated segment and should see high growth for many years. In this industry, larger players enjoy network advantages.
  • Risks: 1) Valuations at PE of 51 times and PB of 14.6 times (TTM) are expensive. 2) Cyber-attacks or other security breaches could affect business 3) their loans portfolio is largely unsecured.
  • Opinion: Investors can SUBSCRIBE to this IPO with a 2 year perspective.

Here is a note on Indian SBI Cards and Payment Services (SBIC) IPO.

IPO highlights

  • The IPO opens: 2-5th Mar 2020 with the Price band: ₹750-755 per share.
  • Shares offered to public number 13.86 cr. The FV is ₹ 10 and market Lot is 19. The IPO in total will collect ₹10,355 cr. while selling 14.6% of equity.
  • The promoter group owns 74% in SBIC which will fall to 69% post-IPO. SBIC is a subsidiary of SBI, a PSB and India’s largest commercial bank in terms of deposits, advances and branches.
  • The IPO offer includes a fresh issue of shares and sale by current shareholder (OFS). The fresh issue proceeds would be ₹500 cr. and the OFS proceeds would be ₹9,855 cr. at UMP.
  • The IPO share quotas for QIB, NIB and retail are in ratio of 50:15:35.
  • CA Rover Holdings (Non Promoter – Non Public shareholder) owns the remaining 26% Pre-IPO in SBIC. CA Rover is controlled by Carlyle Group, a global investment firm with $222 bn. of AUM (FY19).
  • The unofficial/ grey market premium for this IPO is ₹350/share. This is a positive.

Introduction

  • SBI Cards offers credit cards (CC) to individual cardholders and corporate clients in segments – lifestyle, rewards, travel and fuel, shopping, banking partnership cards and corporate cards. These cover all major cardholder segments in terms of income profiles and lifestyles.
  • Revenues, EBITDA and profit for FY19 were ₹6,999 cr., ₹2,430 cr. and ₹863 cr. resp. PAT for H1 FY20 is ₹725 cr. It has 3,783 employees (Sep 2019).
  • SBIC is the 2nd largest CC issuer in India, with 18.1% share in terms of cards and a 17.9% share by spends (per RBI). SBIC has grown faster than the market over last 3 years both in numbers and spends. From FY17-19, SBIC’s total CC spends grew at a 54.2% CAGR (35.6% CAGR for the CC industry) and the number of cards grew at a 34.5% CAGR (25.6% CAGR for the overall CC industry).
  • SBIC has a broad CC portfolio that includes SBI as well as co-branded CCs. See Exhibit 2. They offer 4 primary SBI branded CCs: SimplySave, SimplyClick, Prime and Elite, each catering to different needs. SBIC is also the largest co-brand CC issuer in India and has partnerships with several major players in the travel, fuel, fashion, healthcare and mobility industries. SBIC issues its CC in partnership with the Visa, MasterCard and RuPay payment networks.
  • SBIC acquires customers using multiple channels. They have deployed a sales force of 32,677 outsourced personnel in 145 cities to engage prospects through physical PoS in bank branches, retail stores, malls, fuel stations, railway stations, airports, corporate parks and offices, as well as through tele-sales, online channels, email, SMS marketing and mobile apps. SBIC has a presence in 3,190 open market points of sale. In addition, the partnership with SBI provides them with access to their network of 21,961 branches, and enables them to market CCs to their customer base of 44.5 cr.
  • SBI earns its revenues from (a) Interest Income (b) Fee base income. For breakup, see Fig 1(a).

jainmatrix investmentsjainmatrix investments, sbi cards IPOFig 1(a) SBIC FY19 Operating Revenue and Fig 1(b) Revenue over FY17-19, and Fig 1(c) Fees & Services Details

  • SBIC has a diversified revenue model whereby they generate both non-interest income (fee based income such as interchange fees, late fees and annual fees) as well as interest income on CC receivables. SBIC’s operating model is focused on the cardholder’s 2 main financial needs: transactional needs and short term credit.
  • Interest income is earned when cardholders roll over their dues. SBIC earns interest income on its assets (receivables) when card holders don’t make payment in full when they are due.
  • Fee based income is earned by levying fees and charges to its cardholders. These are categorized as (a) Subscription-based fees: consist of CC membership fees and annual CC fees charged to cardholders. (b) Spend-based income: is interchange fees that the co. earns as consideration for the transactions on using the CCs. In addition, they also earn forex markup income on international transactions (c) Instance-based fees: instance-based fees include late fees, reward redemption fees, cash withdrawal fees, overlimit fees, payment dishonour fees, processing fees or service charges for cross-sell or value added products, statement retrieval charges, among others. See Fig 1(c).

jainmatrix investments, sbi cards ipoFig 2 – SBIC personal CC portfolio details

    • As of 9M FY20, the personal cards portfolio (Fig 2) had 9.99 m. cards. In addition to personal cards SBIC offers corporate cards and white label ATM cards. White label CCs are partner-branded CCs that carry the brand partner’s logo only. They also offer 1 white label CC with partner Tata Sons.
    • Leadership is Rajnish Kumar (C’man), Hardayal Prasad MD-CEO, Richhpal Singh COO, Nalin Negi CFO

News, Updates and Strategies

  • The IPO of SBIC got delayed from Dec 2019 to Mar 2020 as there was an investigation by SEBI of SBI MF over share trading allegations of Manappuram Finance. The ok for IPO was finally given by SEBI.
  • cost of share acquisition by CA Rover Holdings was Rs 81. The partial exit is at a 9.25X gain.
  • SBIC launched a co-branded CC with Vistara in Nov 2019 with variants Club Vistara and PRIME.
  • SBIC in Dec 2019 has made an application to list CPs for an issue size of ₹400 cr. to the BSE.
  • SBIC’s business strategy is:
    • To expand its customer acquisition capabilities and grow the cardholder base. SBIC will increase the number of open market physical points of sale that they operate. They are focused on increasing presence in tier II and tier III cities where their cardholder base has been low so far.
    • To tap into new cardholder segments by broadening the portfolio of CC products.
    • To stimulate growth in CC transaction volumes.
    • To enhance cardholder experience.
    • To continue leveraging technology across their operations.

Digital Payments and CC Industry Outlook in India

  • In CY17, the penetration of CCs in India was 2.2% as compared to 320% in the US, 42% in China and 73% in Brazil, and CC spends as a percentage of GDP stood at 3% as compared to 17% in the US, 25% in Hong Kong and 12% in Brazil. Hence Indian CC market is highly underpenetrated with long runway for growth. SBIC would benefit from the fast evolving youth and spend dynamics.
  • The payments space has seen rapid innovation in the past few years, led by govt. and regulatory initiatives as well as changing consumer preferences. Jan Dhan, Aadhaar and Mobile (JAM), the demonetization of high value currency notes in Nov 2016, implementation of GST and the unveiling of the Unified Payments Interface (UPI) are some of the notable regulatory initiatives that have spurred growth in the digital payments space. New Small Finance Banks and Payment Banks have also brought new innovation, platforms and infra here. Digital payment volumes (including RTGS, but excluding interbank clearing, ECS, NEFT, IMPS, NACH, cards and prepaid instruments) have quadrupled in the last 3 years ending FY19.
  •  In terms of volume, digital payments transactions logged a 5 year CAGR of 49% from FY14-19, owing to factors such as a younger population, rising smartphone penetration, an increase in mobile internet users, increasing convenience of transacting digitally, and a booming ecommerce sector.
  •  The digital payments value in India is expected to more than double to ₹4,055 tn. in FY24 from ₹1,630 tn. in FY19, translating into a 5 year CAGR of 20%.
  • The Indian e-commerce industry has nearly doubled since FY16. CC accounts for 30-35% of ecommerce payment value while cash on delivery accounts for around 50-60%. CC usage has improved by introducing card on delivery/ portable payment options.

jainmatrix investments, sbi cards ipoExhibit 3 – Key metrics of CC players in India

  • Growth in CC volumes has risen up over the years, while annual spending has grown moderately. The no. of CCs issued is 4.7 cr. in FY19, having grown at 20% CAGR over the last 5 years, and is expected to grow by 25% from FY19-FY20, while annual spends per card is expected to grow by 1%.
  • CC spends have registered a robust growth, growing at a CAGR of 32% from FY15-19 to reach ₹6 tn. in FY19, and is expected to reach ₹15 tn. by FY24.
  • There are a total of 74 players offering CCs in India, with the top 3 private banks (HDFC Bank, Axis Bank and ICICI Bank) and SBI Card – as the leading pure-play CC issuer, dominating with a 72% market share by number of CCs as of FY19 and 66% market share by CC spends. See Exhibit 3.

Financials of SBIC

jainmatrix investments, sbi cards ipoFig 4 – SBIC Financials

  • Revenues, EBITDA & PAT have grown at a CAGR of 44.6%, 48.3% and 52.1% resp. from FY17-FY19. The 3 year no’s. are solid with rapid growth, see Fig 4.
  • SBIC for 9M FY20 reported at PAT of ₹1,161 cr., an 89% growth YoY over the same period last year.
  • PBT for 9M FY20 ₹1,619 cr. has grown by 71% YoY over 9M FY19. This is very strong operational performance despite higher provisions for bad debt.
  • EBITDA and PAT margins for SBIC are high and have improved from FY17-19.
  • SBIC had a RoE of 24%. The 3 year average RoE is 24.6%. This is an excellent return ratio.
  • SBIC has paid tax at 35% of PBT in the last 3 years. There can be a substantial profit and RoE increase in FY20 with the reduction to 25% corporate tax.

Benchmarking

We benchmark SBIC against listed private sector banks which have a CC business, a top NBFCs and a top microfinance Bank, as there is no other listed pure play CC player today. See Exhibit 5.

jainmatrix investments, sbi cards IPO

Fig 5 – Benchmarking    Note: 1) Sales & PAT growth for SBI Cards is over FY17-19, so it is 2 year CAGR growth. 2) Market share, avg loan per card o/s & avg spend per card are metrics for only the CC parts of the businesses.

  • PE and PB of SBIC are among the highest in the peer group, only Bajaj Finance, an NBFC leader is higher. Basis these valuations SBIC looks very expensive.
  • The sales and PAT growth for SBIC are also among the highest with only microfinance leader Bandhan doing better. They are growing fast as India’s CC market is highly underpenetrated.
  • SBIC’s NIM’s at 15.5% (FY19) is the highest amongst its peer group. This is a clear stand out which makes SBIC a candidate for high valuation multiples.
  • SBIC has a low D/E indicating that there is headroom for more leverage.
  • The RoE of SBIC for FY19 is the highest amongst the comparables. The 3 year average is high as well and RoE is likely to remain elevated. Dividend yield for SBIC at 1.19% is good.
  • HDFC Bank has the highest market share and SBIC is next. The market is under-penetrated and there is enough headroom for all players to grow. SBIC leads in the avg. spend per card.

Positives for SBIC and the IPO

  • The listing of SBIC will provide investors access to the second largest CC issuer in India and provide the first listed pure-play CC issuer with a 20 year operating history. The high performing BFSI sector in India has another unique and high quality offering with SBIC.
  • SBIC’s financials are robust. SBIC has generated high RoE and NIM, while also maintaining sufficient capital buffer through high CAR & low D/E. This is good financial management by the company.
  • It has the leading revenue and sales growth of the top 4 players, with growing market share.
  • SBIC has diversified customer acquisition capabilities. SBIC is a leading player in open market customer acquisitions in India. They have deployed a large outsourced sales team. When a point of sale is not directly managed by them, they work with their 11 non-bank co-brand partners and 7 co-brand bank partners using their distribution network (including their co-brand partner’s retail outlets), communication channels and customer interactions to market CCs to their customers.
  • The major competitors are more focused on internal marketing of CCs to banking customers.
  • SBIC gets supported by a strong brand and pre-eminent promoter. The relationship with SBI extends to joint promotions, sharing of office space, etc. In fiscals FY19, 18, and 17, new accounts acquired from SBI’s customer base accounted for 55.2%, 45.5% and 35.2%, resp., of SBIC total new accounts.
  • The industry characteristics suggest that the credit cards business has a network effect, so larger players have an advantage over smaller ones of sharing of infrastructure and management costs, easier marketing and benefits deals for customers, etc. Here SBIC has a #2 player advantage.
  • With just 3,783 of its own employees, SBIC has outsourced many activities, improving productivity.
  • SBIC has a good and and diversified portfolio of CC products offering.
  • SBIC has ample potential to tap SBI’s large customer base, for growth.
  • SBIC has an experienced and professional management team. The MD & CEO, Mr. Hardayal Prasad, has over 36 years of experience in the financial services industry. A large number of the senior management personnel have worked with SBIC for a significant period of time, resulting in effective operational coordination and continuity of business strategies.

Risks and Negatives for SBIC and the IPO

  • Valuations at PE 51 times and PB 14.6 times (TTM) are very expensive. On a relative basis, SBIC has valuations just less than Bajaj Finance which has an outstanding 15 year growth and track record.
  • SBIC derives substantial benefits from their existing relationship with their promoter SBI, and a loss or reduction in the level of support they receive from them could adversely affect SBIC.
  • SBIC does not own the ’SBI’ trademark and currently uses it pursuant to a non-exclusive licensing agreement. SBIC pays royalty fees of 2% of their net profit or 0.2% of income, whichever is higher. The licensing agreement may be terminated by SBI on occurrence of events: SBI’s shareholding in SBIC falls below 26%, if they undergo a change of control event, or if they fail to pay royalty to SBI.
  • Several senior officers in SBIC are on deputation from SBI and may return there causing a skills loss.
  • The CC portfolio is of unsecured loans and not supported by collateral. 98.6% of it is unsecured.
  • With 74 players, the sector looks crowded. Competition can rise also if any player decides to commit heavily to the business, with fresh investments. However so far SBIC has handled the pressures well.
  • Cyber-attacks or other security breaches can have a material adverse effect on their business. Cards cloning, phishing, etc. are threats to the business. Coronavirus too can impact consumer sentiment.

Overall Opinion and Recommendation

  • Credit cards are a mid and premium lifestyle product, and are quite habit forming, both in terms of purchases, new services experiences as well as convenience of bill payments. We expect growth to continue for many years.
  • SBIC is a well-managed firm financially. The growth, return ratios and operating metrics are robust.
  • At a 9M FY20 P/B of 14.6 times, the valuation is expensive. However this retail focused fast growing company has good return metrics and should get a premium valuation in the market.
  • Risks: 1) Valuations at PE of 51 times and PB of 14.6 times (TTM) are expensive. 2) Cyber-attacks or other security breaches could affect business 3) their loans portfolio is largely unsecured.
  • Opinion: Investors can SUBSCRIBE to this IPO with a 2 year perspective.

Disclaimer

This document has been prepared by JainMatrix Investments Bangalore (JM), and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of JM. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, JM has not independently verified the accuracy or completeness of the same. Punit Jain discloses that he has been a retail customer of SBIC since 5 years. Other than this JM has no stake ownership or known financial interests in SBIC or any group company. Punit Jain intends to apply for this IPO in the Retail category. Neither JM nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient’s particular circumstances and, in case of doubt, advice should be sought from an Investment Advisor. Punit Jain is a registered Research Analyst under SEBI (Research Analysts) Regulations, 2014. JM has been publishing equity research reports since Nov 2012. Any questions should be directed to the director of JainMatrix Investments at punit.jain@jainmatrix.com.

Reliance Industries – A Firm to Rely On

  • CMP: ₹1,532
  • Industry: Refining, Petrochem, ++ Conglomerate 
  • Large Cap with ₹9,85,000 crore mkt cap
  • Current Valuation: P/E: 23 times and P/B: 2.4 times
  • BUY with a target of ₹2,200 by May 2022 

Summary

  • Overview: Reliance Industries is the largest private sector firm and #1 by market cap in India. RIL has over decades proven its ability to build businesses of global scale and execute complex, time critical, and capital-intensive projects. ~80% of RIL’s operating profits are being generated from the refining and petchem verticals. Going ahead newer businesses like Retail and Telecom are expected to grow profitably. RIL earnings has green shoots from (a) Improving ARPU from Jio wireless business (b) Launch of Jio Fiber Broadband services (c) Traction in enterprise solutions service offering (d) Lower interest costs as RIL aims to become net debt free (e) improving margins and stable growth in Retail and eCommerce.
  • Key Risks: (a) Adverse crude prices/ petroleum margins (b) Inability to reduce debt at the committed pace. (c) Lower plastic consumption affecting the petchem vertical. (d) Muted growth in Indian economy. (e) regulatory changes in telecom
  • Advice: Investors can BUY this share with a May 2022 target price of ₹2,200/share. This will allow their investment to appreciate 42% absolute or 17% annualized over this period.

The entire report in PDF form is available here – JainMatrix Investments_Reliance Industries_Jan2020

Disclaimer and Disclosure

This document has been prepared by JainMatrix Investments Bangalore (JM), and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of JM. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, JM has not independently verified the accuracy or completeness of the same. Punit Jain has no position in Reliance Industries. In addition, JM has no known financial interests in RIL or any related group. Neither JM nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of Investments can go down as well. The suitability or otherwise of any Investments will depend upon the recipient’s particular circumstances and, in case of doubt, advice should be sought from an Investment Advisor. Punit Jain is a registered Research Analyst under SEBI (Research Analysts) Regulations, 2014. JM has been publishing equity research reports since Nov 2012. Any questions should be directed to the director of JainMatrix Investments at punit.jain@jainmatrix.com.

Spandana Sphoorty Financial IPO – A Spunky Player

  • Date 06th Aug; IPO Opens 5-7th Aug at Rs. 853-856
  • Valuations: P/E 17.6 times TTM, P/B 2.4 times (Post IPO)
  • Mid Cap: Rs. 5,505 cr. Mkt cap
  • Industry – NBFC MFI
  • Advice: SUBSCRIBE
  • Overview: Spandana is a rural focused NBFC-MFI with a geographically diversified presence in India. It offers income generation loans under the joint liability group model, predominantly to women from low-income households in rural areas. They are the 4th largest NBFC-MFI and the 6th largest amongst NBFC-MFIs and SFBs in India, in terms of AUM. Revenues, NII and profit for FY19 were ₹1,049 cr., ₹640 cr. and ₹312 cr. resp. Capital adequacy is 39.6% which is very safe. Spandana exited from CDR in March 2017 and the operations are stable now. At a P/B of 2.4 times & PE of 17.6 times (post IPO), the valuation look attractive.
  • Risks: 1) Economically and politically sensitive sector 2) Significant exposure to unsecured loans.
  • Opinion: Investors can SUBSCRIBE to this IPO with a 2 year perspective.

Here is a note on Spandana Sphoorty Financial (Spandana) IPO.

IPO highlights

  • The IPO opens: 5-7th Aug 2019 with the Price band: Rs. 853-856 per share.
  • Shares offered to public number 1.40 cr. The FV of each is Rs. 10 and market Lot is 17.
  • The IPO in total will collect ₹1,200 cr. while selling 21.8% of equity. IPO is both an Offer for Sale by current shareholders (OFS) and a fresh issue of shares. The OFS proceeds would be ₹800 cr. at UMP and fresh issue size is ₹400 cr.
  • The Promoters are Padmaja Gangireddy, VSR Reddy Vendidandi and Kangchenjunga Ltd. that own 81.22% in Spandana which will fall to 62.58% post-IPO. The major selling shareholders are Kangchenjunga, VSR and Padmaja Gangireddy, see Exhibit 1(a). The IPO is being launched to provide partial exit to existing promoters as well as for Spandana to augment the capital base (Fresh Issue).

jainmatrix investments, spandana IPO

Exhibit 1(a) – IPO Selling Shareholders; Exhibit 1(b) – Shareholding pattern

  • The IPO share quotas for QIB, NIB and retail are in ratio of 50:15:35.
  • The promoter Kangchenjunga Ltd is a holding co. incorporated in Mauritius. It is a private company with limited liability, which holds a Category 1 Global Business License to carry out activities as an investment holding company and to acquire, invest in and hold securities of Spandana. The Class A shareholders of promoter Kangchenjunga are seen in Exhibit 1(b).

The unofficial/ grey market premium for this IPO is Rs. 18-20/share. This is small.

Introduction

  • Spandana is a rural focused NBFC-MFI with a geographically diversified presence in India. It offers income generation loans under the joint liability group model, predominantly to women from low-income households in rural Areas. As of FY19, they were the 4th largest NBFC-MFI and the 6th largest amongst NBFC-MFIs and SFBs in India, in terms of AUM. See Exhibit 2(a).
  • Revenues, NII and profit for FY19 were ₹1,049 cr., ₹640 cr. and ₹312 cr. resp. It has 7,062 employees (June 2019). 85% of their gross loans were Abhilasha loans, and 86% of the loan book is unsecured.

jainmatrix investments, spandana IPO

jainmatrix investments, spandana IPO

Fig 2a – Loan products (above) and Fig 2b AUM Spread

  • Spandana was incorporated as a public company in 2003 and registered as an NBFC with the RBI in 2004. Soon they registered as an NBFC-MFI in 2015. In October 2010, the MFI industry (including Spandana) was severely impacted as the govt. of AP promulgated the AP Microfinance Ordinance 2010, which enforced several restrictions on the operations of MFIs. This impacted Spandana collections, cash-flow, its ability to service debt, and so their growth and profitability.
  • Spandana’s lenders referred them to the corporate debt restructuring (CDR) mechanism of RBI to restructure borrowings and revive business. The CDR plan allowed them to get cash-flow relaxations to continue their portfolio diversification, process improvement and cost rationalization. Their operations turned profitable from FY14.
  • Spandana exited CDR in March 2017, which enabled it increase lender base, diversify its borrowings to new banks and NBFCs and also issue NCDs in the capital markets. As a result, during FY18, with increasing flow of capital, they expanded their operations and were able to utilize the existing branch network and employees (earlier underutilized due to lack of capital). Prior to their exit from CDR in 2017, they had limited access to capital, due to which they had to offer loans in lower ticket sizes than the demand from clients.
  • Distribution is strong as in 2019 they cover 16 states and 1 UT across India through 929 branches.
  • Leadership – Padmaja Gangireddy (MD), Sudhesh Chandrasekar (CFO), Abdul Khan (Strategy Officer).

News, Updates and Strategies of Bandhan

  • Prior to 2010 Andhra Pradesh MFI crisis, 51% of Spandana loan book was concentrated in AP. Post the debacle they have tightened internal controls to manage risk better by restricting (a) loan book exposure to a max of 22.5% for 1 state (b) loan book exposure to a max of 2.5% for each district (c) loan book exposure to a max of 0.3% for each branch.
  • Spandana’s business strategy is as follows:
  • To leverage their popular income generation loan products to derive organic business growth.
  • To leverage existing branch network by increasing loan portfolio and employee productivity.
  • To increase its presence in under-penetrated states and districts.
  • To further diversify their borrowing profile; and reduce their cost of borrowings.

Various shareholders invested in Spandana over the years. The average cost of acquisition per share for those shareholders is as follows:

jainmatrix investments, spandana IPO

Exhibit 3 – Cost of shares by investors

  • In Jun 2018 20.3L shares were allotted to Padmaja Gangireddy and 72K shares to Abdul Feroz Khan by private placement at Rs. 235.4/share. In IPO this has grown by 3.6 times in just over a year.
  • Spandana has raised Rs 360.28 cr. from 18 anchor investors by allotting 42,08,886 shares at a price of Rs 856, the upper band of its IPO. Among the 18 anchor investors, Wells Fargo Emerging Markets Equity Fund, Goldman Sachs India Ltd, ICICI Prudential Life Insurance Company and Bajaj Allianz Life Insurance Company have been allotted about 4.40 lakh shares each.
  • Spandana IPO was subscribed 6% on the first day of bidding on Monday (5th Aug).

Micro Finance and Banking Industry Outlook in India

  • Financing needs in India have risen along with economic growth over the past decade. By complementing banks and other financial institutions, NBFCs help meet this need.
  • MFI is a volatile sector that can be badly affected by economic and political events. Spandana’s operations were also affected post AP ordinance in 2010. It went into CDR however later came out of it in Mar 2017. In Nov 2016, the Indian government announced the demonetization of currency notes of ₹500 and ₹1,000 denominations. Though demonetisation affected the retail sector’s credit performance in FY17, which dropped 300 bps from FY16, growth remained higher than industrial and agricultural credit growth in FY17. The retail segment was negatively impacted by the demonetization driven slump in the real estate sector. Retail credit grew 16% YoY, while industrial credit contracted YoY by 2%. Such events have affected collection efficiencies which could happen in the future as well.
  • Spandana has a 2.6% market share basis its GLP. See Exhibit 4

jainmatrix investments, spandana IPO

Exhibit 4 – Market share and AUM growth for MFI players over the years

  • The share of adults with a bank account in India has more than doubled to approximately 80% since 2011, largely supported by the Pradhan Mantri Jan Dhan Yojana (PMJDY) a scheme of the GOI, which led to account growth and traction in savings. However, while significant traction is present on the deposit side, India is still among the Top 3 nations with unbanked people in the world, reflecting the strong need for an enhancement of the financial inclusion agenda.
  • The microfinance sector in India has grown at a CAGR of 23.1% over the past 10 years to reach ₹2,633 bn. as of FY19, despite some setbacks that have impacted the industry’s growth. The industry has evolved over time, starting with the Self-Help Group (SHG) Bank Linkage program and not-for-profit organisations (NGOs) being the key participants in the sector, to the scaling of NBFCs, the conversion of Bandhan Financial Services into a universal commercial bank and the launch of the Small Finance Banks. Presently, the demand for micro credit is primarily being serviced by industry participants such as MFIs, NBFC-MFIs, SHG, Banks, SFBs, NGOs, and other informal lenders.
  • The MFI sector has potential to grow the client base as well as ticket size per borrower. The micro-credit opportunity is about ₹5-6 tn. supported, considering the addressable market of low-income households in India. The traction in disbursements is expected to sustain and the industry is projected to witness a portfolio growth in the range of 20-24% p.a. over the medium term. Within this, the pace of growth of the non-SHG portfolio is expected to be higher at 25-30% p.a. Further, the ticket sizes are likely to go up in the states where the penetration levels are high. Overall client growth may be 8-10% and loan outstanding per borrower may increase by 12-15%.
  • Current challenges in the Indian BFSI sector include the collapse of IL&FS, a liquidity shortage in the BFSI sector, an NPA crisis in PSBs, real estate loans troubles and weakness in DHFL and Yes Bank.
  • Per management, MFI customers are unaffected by these industry events and are doing better.

Financials of Spandana

jainmatrix investments, spandana IPO

Fig 5 – Spandana Financials

Note: 1) Data for FY15-FY16 are per Indian GAAP, FY17-FY19 is basis IND AS with FY18-FY19 are consolidated 2) NIM or Net Interest Margin = Net Interest Income / Annual Average Gross AUM (%)* 3) NIM-R is net interest margin computed as Average Interest Charged less Average Cost of Borrowing. 4) Diluted EPS has been calculated after considering fresh shares to issued post IPO.

  • Spandana’s revenues, NII and PAT over the years are in Fig 5. Revenues, NII & PAT have grown at 33.9%, 34.5% and 31.2% resp. from FY15-FY19. These are good growth numbers.
  • Spandana had a RoE of 16.51% and RoA of 8.2% in FY19. This is moderate and sustainable as the business operations have stabilized now. NIM and NIM-R have stabilized for Spandana over the last 3 years. NIM at 16.39% for FY19 is the highest in the industry.
  • The PAT for FY17 surged 82.3% as it took a deferred tax credit of ₹421 cr. PBT for FY17 was ₹35 cr.
  • Spandana has the best asset quality in the industry. The NNPA as of FY19 stood at 0.02%. The NPA’s have largely come from unsecured personal loans, agri loans as well as MSME loans.
  • NBFCs are required to maintain a CRAR consisting of Tier I and Tier II capital which should not be less than 15% of its aggregate risk weighted assets on-balance sheet and of risk adjusted value of off-balance sheet items. The Tier-I capital was required to not be less than 8.5% by FY16 and 10% by FY17. Spandana has an aggregate CRAR of 48.96% and Tier 1 capital to the extent of 48.52%. This is much higher than what RBI has prescribed which is a positive.

Benchmarking

We benchmark Spandana against peers, See Fig 6.

jainmatrix investments, spandana IPo

Fig 6 – Benchmarking

  • PE of Spandana is the lowest in the peer group. This makes the offering attractive on relative basis.
  • In terms of PB, the valuations are average. This is on an adjusted basis post dilution.
  • The 3 year sales and PAT growth is robust. However Bandhan continues to be the sector leader. The Cost/Income ratio too is low. The PAT margin (PAT/Income) as well as the NIM is highest amongst the peer group. This is a positive. The RoE is average among peer group.
  • GNPA is very high while NNPA is fine. The reason for this is loans outstanding from the AP crisis of 2010. However these are provided for by Spandana.
  • Overall we see Spandana as a MFI rapidly emerging from CDR and stabilizing operations well.

Positives for Spandana and the IPO

  • Spandana has suffered heavily and learnt its lessons in the 2010 AP MFI debacle. It emerged from CDR in 2017 after repairing its books. It now has geographically diversified operations which help in risk containment and business resilience. It also will target 25% CAR to ensure safety of operations.
  • They have a good branch network, with a current AUM of Rs 5 cr. /branch. Per management the focus now will on assets growth to Rs 10 cr. / branch.
  • Spandana’s growth has been achieved despite difficult conditions in MFI industry. After the AP crisis in 2010, there was demonetisation in 2016 and many farm loan waivers. But Spandana did well.
  • The asset quality of Spandana is robust with NNPA at 0.02% for FY19. Financially the firm is well managed with moderate return ratios, superior margins and has high growth rates. The IPO valuations at PE of 17.6 times and PB 2.4 times are also attractive.
  • Spandana has an experienced management team. Ms. Padmaja Gangireddy has 24 years of experience in Indian MFI.

Risks and Negatives for Spandana and the IPO

  • Spandana’s MFI loan portfolio is unsecured, and in the event of non-payment by a borrower, they may be unable to collect the unpaid balance.
  • The operations are still concentrated in the states of Karnataka, MP, Orissa, Maharashtra and Chhattisgarh. Any adverse developments in these states could affect business.
  • The promoters and certain directors have entered into ventures that may lead to potential conflicts of interest with their business. For instance, their Individual Promoter, Padmaja Gangireddy, owns 68.3% shareholding in Abhiram Marketing, a group company engaged in consumer goods, whose retail products are sold at their branches (and from whom they receive a sales commission). There is no assurance that the interests of Abhiram Marketing will align with Spandana’s business interests.
  • Any downgrade of Spandana’s credit ratings may increase their borrowing costs and constrain their access to capital and debt markets and, as a result, may adversely affect their results of operations.
  • MFI industry has enjoyed high growth and margins for the last few years. However the market may be getting crowded with several Private Banks acquiring or setting up MFI subsidiaries, Bandhan Bank getting a universal license and many MFIs getting SFB license.

Overall Opinion and Recommendation

  • The microfinance sector promises to extend credit to the underbanked and informal sector people for financial services penetration into rural India. The potential is immense and is barely tapped.
  • Spandana has a decent size, strong financial performance, recent recovery, good asset quality and an experienced management.
  • It is now the 4th largest NBFC-MFI with AUM, and post CDR has grown rapidly. It has a different DNA and may remain sharply focused on a national presence in only MFI loans for the next few years.
  • The management appears conservative and should able to target growth with lower risk taking.
  • At a P/B of 2.4 times & PE of 17.6 times (post IPO), the valuation look attractive.
  • Opinion: Investors can SUBSCRIBE to this IPO with a 2 year perspective.

Download Report:

The entire report can be downloaded, Click JainMatrix Investments_Spandana IPO_Aug2019

Disclaimer

This document has been prepared by JainMatrix Investments Bangalore (JM), and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of JM. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, JM has not independently verified the accuracy or completeness of the same. JM has no stake ownership or known financial interests in Spandana or any group company. Punit Jain intends to apply for this IPO in the Retail category. Neither JM nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient’s particular circumstances and, in case of doubt, advice should be sought from an Investment Advisor. Punit Jain is a registered Research Analyst under SEBI (Research Analysts) Regulations, 2014. JM has been publishing equity research reports since Nov 2012. Any questions should be directed to the director of JainMatrix Investments at punit.jain@jainmatrix.com.

IndiGo – Spreading Wings but Oil Squeeze

  • Date: 09th May 2019
  • Industry – Airlines 
  • CMP: Rs 1,575 
  • Large Cap of Rs 58,000 cr. mkt cap 

jainmatrix investments, indigo airlines

  • Overview: IndiGo is the market leader in Indian aviation with a low cost carrier model. It has a dominating domestic market share of 46.9%. The revenue and profit were Rs 23,967 crores and Rs 2,242 cr. resp. for FY18. The Income, EBITDA and profits have grown 31.6%, 26.6% and 21.3% CAGR over 8 years. The aggressive growth plans are in place for capacity addition. The Airline industry in India is going to see massive growth. With a big population, low penetration and weak railway sector, it should continue to grow at 15% over next few years. IGO has a strong brand and a leading domestic market share, consistent delivery and high growth. It has executed well on its LCC strategy. IGO has expanded the market with its growth. It will continue to dominate Indian skies due to network effect and good capacity additions. The IGO share is high due to market share gains, the Jet failure and Boeing grounding, inspite of high ATF prices. However there are several risks.
  • Key risks: 1) crude price rise affects ATF prices leading to sharp profit falls 2) large sector capacity adds puts pressure on prices 3) The risk of an engine failure is still there

Get the recommendation and research report: JainMatrix Investments_IndigoAir_May2019

Disclaimer

This document has been prepared by JainMatrix Investments Bangalore (JM), and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of JM. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, JM has not independently verified the accuracy or completeness of the same. Punit Jain discloses that he has been an investor in IGO since Nov 2015. He has also flown Indigo Airlines several times as a normal paying customer. Other than this JM has no known financial interests in IGO or Interglobe Aviation or any related firm. Neither JM nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient’s particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Punit Jain is a registered Research Analyst under SEBI (Research Analysts) Regulations, 2014. JM has been publishing equity research reports since Nov 2012. Any questions should be directed to the director of JainMatrix Investments at punit.jain@jainmatrix.com.